je.st
news
Gilead: What's Ahead In 2015 For This Biotech Juggernaut
2014-12-21 00:05:58| Biotech - Topix.net
Biotech juggernaut Gilead Sciences has provided its shareholders with better than a 30% gain in 2014 so far as we head into the end of the year. Although the stock has spent the last three months consolidating those gains in a relatively narrow trading range, the direction for 2015 remains up.
Tags: ahead
biotech
juggernaut
gilead
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||